News

A ground-breaking project announced by the British Prime Minister David Cameron in 2012, the 100,000 Genomes Project is sequencing 100,000 whole genomes from 70,000 National Health Service (NHS)

Published in the February 2016 edition of Clinical Trials: Journal of the Society for Clinical Trials, the analysis identifies different factors, such as therapeutic area, patient recruitment, administrative

About 85 percent of NHL is of B-cell lineage, and CD19 is broadly expressed across all subtypes of B-cell malignancies. SGN-CD19B is a novel antibody-drug conjugate (ADC) targeted

TAF is a novel, targeted prodrug of tenofovir that has demonstrated high antiviral efficacy similar to Gilead’s Viread® 245 mg of tenofovir disoproxil (as fumarate) (TDF) at one-tenth

Growing evidence has suggested high levels of intense exercise may actually damage your heart causing permanent structural changes resulting in an abnormal heart rhythm. A review published in

Precision BioSciences’ ARCUS genome editing technology will be used to develop an allogeneic chimeric antigen receptor (CAR T) cell therapeutic pipeline directed towards areas of major unmet need

Last December, AstraZeneca agreed to acquire a 55% stake in privately-owned biotech firm Acerta Pharma for $4bn. Acalabrutinib has been recommended as an orphan product for chronic lymphocytic

California-based Vantage Oncology offers radiation oncology, medical oncology and other cancer care services. It will add over 50 cancer centers across 13 US states to McKesson’s business. Biologics

"Receiving orphan drug status in the EU is another encouraging step in the development of RE-024 for the treatment of PKAN," said Alvin Shih, M.D., executive vice president